Steve Anthony: True Canadian Pharmacy

I have not heard if Health Canada is looking into these issues on our side of the border or not…
Canada’s Apotex Inc could face a freeze on new drug applications in the United States as well as a ban on products entering the country after the U.S. Food and Drug Administration warned it of a number of manufacturing breaches at a Toronto factory.
The June 25 warning, which followed a late 2008 inspection of the Etobicoke, Ontario facility, cited !–more– a number of manufacturing deviations from U.S. manufacturing codes.
Among the breaches, the agency charged that Apotex did not thoroughly investigate the failure of batches of some drugs and also noted an unusual high number of rejected batches.
This, the FDA suggested in the letter, demonstrates a lack of adequate process controls and raises significant concerns regarding the capability and reliability of (Apotex’s) processes to consistently manufacture drug products meeting predetermined specifications.

br /br /canadapharmacynews.com

A P.E.I. man has raised the alarm about the rising cost of prescription drugs after the drug he uses to treat depression more than doubled in price this month.
Tom Clark of Murray Harbour, in eastern P.E.I., has been taking trimipramine for 19 years, but he got a shock Thursday when he tried to refill the prescription.
“It went from $45 to $105 in less than a month,” said Clark.
Trimipramine is made by Canadian drug maker Apotex. The company (more…)